Last reviewed · How we verify

NCT03455413

Quality of Perioperative Invasive Ventilation in PICU

Completed Last updated 24 November 2020
What this trial tests

trial testing Swisstom BB2 EIT device in Invasive Ventilation in 20 participants. Completed in 6 October 2020.

Timeline
3 August 2018
Primary endpoint
6 October 2020
6 October 2020

Quick facts

Lead sponsorUniversity of Oulu
StatusCompleted
Study typeOBSERVATIONAL
Enrollment20
Start date3 August 2018
Primary completion6 October 2020
Estimated completion6 October 2020
Sites1 location across Finland

Drugs / interventions tested

Conditions studied

Sponsor

University of Oulu

Who can join

Adults 2 Hours to 1, any sex, with Invasive Ventilation or Elective Surgery. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is purely observational study in which quality of invasive ventilation is observed with electrical impedance tomography (EIT) during perioperative intensive care. EIT parameters will be used to assess if protective ventilation strategies are successfully followed during routine care.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Swisstom BB2 EIT device

Trials testing the same drug.

Other University of Oulu trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03455413.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing